COMMENTARY
Recent Topics in Hopeful Drugs and Candidates with Unique Mode of Action: 1
Pharma Forum Institute and Japan Pharma Licensing Association (JPLA) Keiji Nakamura, Ph. D. Most of the pharmaceutical companies in the world are quite anxious to discover new candidates while they face a severe patent cliff, a sharp decline in prescriptions,…
To read the full story
Related Article
COMMENTARY
- Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise
December 22, 2025
- FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed
December 9, 2025
- MOF Autumn Proposals Signal a Shift from Drug Pricing to Cost-Sharing Reform
November 17, 2025
- Japan’s Trading Houses Gain Ground in Pharma, Rewriting the Industry Playbook
November 10, 2025
- The Price of Stability: Who Bears Japan’s Drug Distribution Burden?
October 27, 2025
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…





